Specialities

Psychiatry

Clinical Neuroscience

JULY 30, 2024

An update on approved and emerging drugs for the treatment of postpartum depression

ELIF Asena ÇULCU, ŞENIZ DEMİRYÜREK, ABDULLAH Tuncay DEMİRYÜREK

Depression, anxiety and psychotic disorders are common perinatal mental health disorders in the postpartum period. Depressive symptoms that occur postpartum are also present in the prenatal period in 50% of patients. Risk factors for the development of postpartum depression include poor relationship with the partner, lack of social support, mother’s low socioeconomic status and multiparity.

Clinical Neuroscience

JULY 30, 2024

Effect of COVID-19 on seizures and patient behavior in people with epilepsy

GÖNÜL AKDAĞ, NIYAZI UYSAL, MUSTAFA ÇETİNER, FATMA AKKOYUN ARIKAN, SIBEL CANBAZ KABAY

To evaluate the long-term effects of the COVID-19 pandemic on seizure frequency and levels of mental distress in individuals with epilepsy and identify potential risk factors associated with increased seizure frequency. This is a cross-sectional study conducted in Türkiye in May 2021 by phone. Information on epilepsy syndromes, antiseizure medications, average seizure frequency, and drug resistance was obtained from medical records.

Lege Artis Medicinae

JUNE 25, 2024

[Behavioural and mental symptoms in neurocognitive disorders   ]

HIDASI Zoltán, FULLAJTÁR Máté

[Dementia and mild cognitive impairment belong to neurocognitive disorders. Alz­heimer’s disease, dementia with Lewy-bo­dies, frontotemporal dementia and vascular dementia there are most typically in their background. Along with cognitive symp­toms, behavioural and mental signs are important parts of its symptomatology, with significant burden for patients and relatives alike. From clinical point of view, behavioural and mental symptoms are multifaceted, diverse, and heterogeneous, their de­finition and classification is not standardized thus multiple approaches are viable. Complex pathomechanism may hide in the background of these conditions. With biological (neurodegenerative, neurobiological, and other medical) causes, psychogene and social factors can contribute to their clinical manifestation. First, accurate mapping of background factors of symptoms opens the way to individually tailored treatment that may combine non-pharmaceutical and pharmaceutical op­tions. Detailed recognising and complex the­rapeutic plan provide together the real choice for efficient treatment of behavioural and mental symptoms. ]

Lege Artis Medicinae

JUNE 25, 2024

[Artificial intelligence for general practitioners – Literature review ]

MÓCZÁR Csaba

[Huge amount of data is generated while providing health care. Yet, there was the same huge progress in processing large databases with technological development of artificial intelligence in the recent years. Practical applications of artificial intelligence are increasingly established in healthcare, including the family medicine too. This study provides an overview of the international literature on artificial intelligence applications in family medicine. Complex, connected systems do not exist for the time being. Mainly the prediction of specific diseases (e.g., chronic kidney failure, diabetes mellitus, dementia, etc.), facilitating the data management, and supporting decision-making mechanisms are tested actually by specific methods of artificial intelligence for experimental reasons. The rate of technological progress is enormous, but with enthusiasm about the future, we must also be aware of potential dangers of this technology. ]

Clinical Neuroscience

MAY 30, 2024

Cognitive impairment in long-COVID

JULIDE TOZKIR, CIGDEM TURKMEN, BARIS TOPCULAR

Long Covid is a complex condition characterised by symptoms that persist for weeks and months after the Covid infection, accompanied by cognitive im­pairment that negatively affects daily life. Understanding this complex condition is important for the development of diagnostic and therapeutic strategies. This article aims to provide a comprehensive overview of cognitive impairment in long-COVID.

1.

Lege Artis Medicinae

2024;34(9)
2024 04. OCT

2.

Lege Artis Medicinae

2024;34(9)
2024 04. OCT

3.

Lege Artis Medicinae

2024;34(9)
2024 04. OCT

4.

Lege Artis Medicinae

2024;34(9)
2024 04. OCT

5.

Lege Artis Medicinae

2024;34(9)
2024 04. OCT